Attached files

file filename
8-K - 8-K - S&W Seed Cosanw-8k_20200212.htm

 

EXHIBIT 99.1

 

S&W Announces First Half and Second Quarter Fiscal 2020 Financial Results

 

Conference call to be conducted on Friday, February 21, 2020 at 10:30 am ET

 

For Immediate Release

Company Contact:Investor Contact:

Matthew Szot, Chief Financial Officer Robert Blum

S&W Seed CompanyLytham Partners, LLC
Phone: (720) 506-1164Phone: (602) 889-9700
www.swseedco.comsanw@lythampartners.comwww.lythampartners.com

LONGMONT, Colorado – February 12, 2020 – S&W Seed Company (Nasdaq: SANW) today announced financial results for the first half and second quarter of fiscal year 2020 ended December 31, 2019.

 

“Our financial results for the first half and second quarter of fiscal year 2020 are in line with our expectations as our refined sales and marketing approach continues to result in growth in our core business,” commented Mark Wong, President & CEO of S&W Seed Company. “I believe we continue to be well-positioned to deliver core revenue growth and gross margin expansion as we enter the high-volume selling season, which we expect to be driven by the investments we have made to integrate and align our sales organizations to benefit from a multi-crop portfolio.”

“We continue to make excellent progress bringing to market herbicide tolerance that will allow over-the-top grass control in sorghum. Our ACCase Tolerant Sorghum (“ATS”) trials in calendar year 2019 showed good crop tolerance and excellent hybrid performance. We have further research and collaborator trials planned for calendar year 2020 which will be designed to refine crop safety parameters and verify hybrid performance with multi-location strip trials planned to demonstrate hybrids, crop safety and weed control on a commercial scale,” Mr. Wong continued. “At the same time, we are working on regulatory packages for herbicide registration and export approvals for the grain produced from ATS fields. Seed production of the first ATS hybrids planned for 2020 is expected to provide small quantities for initial commercial introduction in 2021. Grain produced from the 2021 crop will likely be sold in the U.S. only, but we expect to have full export approvals and seed supply to meet 2022 demand.”

Mr. Wong concluded, “We are working diligently to pursue accretive acquisitions that will leverage our operating infrastructure, including our enhanced sales and distribution capabilities. Our objectives include continuing to broaden our product offerings and sales capabilities, with a focus on geographies where we have an established presence to facilitate cross-selling of our existing portfolio. Further, we plan to look for unique technologies that we can leverage through applications to other products or geographies and add incremental value on a go-forward basis. Given the strength of our balance sheet, which includes significant availability on our credit facilities, I believe we are well positioned to execute on this strategy.”

 


 

Financial Results

Core Revenue (excluding product revenue attributable to Pioneer) for the first half of fiscal 2020 was $18.2 million, compared to Core Revenue for the first half of fiscal 2019 of $15.5 million, an increase of approximately 17%. Core Revenue for the second quarter of fiscal 2020 was $9.2 million, compared to Core Revenue for the second quarter of fiscal 2019 of $8.9 million. As announced in May 2019, S&W entered into a termination agreement and an alfalfa license agreement with Pioneer Hi-Bred International, a subsidiary of Corteva Agriscience, to replace its prior alfalfa distribution agreement with Pioneer. Due to these agreements signed with Pioneer, S&W discloses Core Revenue as a metric to track performance of its business on a go-forward basis. The increase in Core Revenue for the first half and the second quarter of fiscal 2020 can be primarily attributed to year over year growth in the Company's alfalfa operations.

Total revenue for the first half of fiscal 2020 was $24.6 million, compared to total revenue for the first half of fiscal 2019 of $44.7 million. Total revenue for the second quarter of fiscal 2020 was $12.4 million, compared to total revenue of $18.6 million in the second quarter of fiscal 2019. Under the new agreements with Pioneer, Pioneer paid $45.0 million to S&W in May 2019 and an initial quarterly payment of $5.6 million in September 2019, with S&W expecting to receive an aggregate of $19.5 million in additional quarterly payments through February 2021. For the first half of fiscal 2020, S&W recorded product revenue from Pioneer of $6.4 million under the new agreements, which was a decrease of $22.8 million from the first half of fiscal 2019.

Gross margins during the first half of fiscal 2020 were 21.4% compared to gross margins of 22.7% in the first half of fiscal 2019. Gross margins during the second quarter of fiscal 2020 were 17.7% compared to gross margins of 25.2% in the second quarter of fiscal 2019. The change in gross margins for the first half and second quarter of fiscal 2020 is primarily due to a change in sales mix as our prior year sales consisted of a higher concentration of sales to Pioneer.  S&W expects to see improvement in gross margins as the hybrid sorghum sales season ramps up.

In the first half of fiscal 2020, adjusted operating expenses, excluding transaction costs (see Table A2), were $15.1 million, compared to $10.5 million in the first half of fiscal 2019. In the second quarter of fiscal 2020, adjusted operating expenses, excluding transaction costs (see Table A1), were $8.0 million, compared to $6.2 million in the second quarter of fiscal 2019. The increase in adjusted operating expenses for the first half and second quarter of fiscal 2020 can be attributed to additional expenses from the newly acquired sorghum operations of Chromatin and additional investments in S&W's sales and marketing and product development functions.

GAAP net loss for the first half of fiscal 2020 was $(11.6) million, or $(0.35) per basic and diluted share, compared to GAAP net loss of $(2.7) million, or $(0.10) per basic and diluted share, in the first half of fiscal 2019. GAAP net loss for the second quarter of fiscal 2020 was $(6.7) million, or $(0.20) per basic and diluted share, compared to GAAP net loss of $(2.8) million, or $(0.09) per basic and diluted share, in the second quarter of fiscal 2019.

Adjusted non-GAAP net loss (see Table A2) for the first half of fiscal 2020 was $(10.7) million, or $(0.32) per basic and diluted share, which excluded transaction costs, change in estimated value of assets held

 


 

for sale, loss on extinguishment of debt, and interest expense – amortization of debt discount. Adjusted non-GAAP net loss (see Table A2) for the first half of fiscal 2019, excluding transaction costs and interest expense – amortization of debt discount, was $(1.6) million, or $(0.06) per basic and diluted share.

Adjusted non-GAAP net loss (see Table A1) for the second quarter of fiscal 2020 was $(6.2) million, or $(0.19) per basic and diluted share, which excluded transaction costs, change in estimated value of assets held for sale, and interest expense – amortization of debt discount. Adjusted non-GAAP net loss (see Table A1) for the second quarter of fiscal 2019, excluding transaction costs and interest expense – amortization of debt discount, was $(2.1) million, or $(0.07) per basic and diluted share.

Adjusted EBITDA (see Table B) for the first half of fiscal 2020 was $(6.9) million, compared to adjusted EBITDA of $1.9 million in the first half of fiscal 2019. Adjusted EBITDA (see Table B) for the second quarter of fiscal 2020 was $(4.2) million, compared to adjusted EBITDA of $(0.2) million in the second quarter of fiscal 2019.

Outlook

S&W continues to expect Core Revenue (excluding revenue attributable to Pioneer) for fiscal 2020 to be within a range of $41 to $44 million, representing an expected increase of 9% to 16% compared to fiscal 2019 Core Revenue of $37.9 million.

Including contributions from Pioneer, S&W continues to expect total revenue for fiscal 2020 to be within a range of $64 to $67 million.

S&W expects gross margins for fiscal 2020 to be within a range of 23% - 25%.

Conference Call

S&W Seed Company has scheduled a conference call for Friday, February 21, 2020, at 10:30 am ET (7:30 am PT) to review these results. Interested parties can access the conference call by dialing (844) 861-5498 or (412) 317-6580 or can listen via a live Internet webcast, which is available in the Investor Relations section of the Company's website at http://www.swseedco.com/investors. A teleconference replay of the call will be available for three days at (877) 344-7529 or (412) 317-0088, confirmation # 10139137. A webcast replay will be available in the Investor Relations section of the Company's website at http://www.swseedco.com/investors for 30 days.

Non-GAAP Financial Measures

In addition to financial results reported in accordance with accounting principles generally accepted in the United States of America (“GAAP”), we have provided the following non-GAAP financial measures in this release and the accompanying tables: adjusted EBITDA; adjusted non-GAAP net income (loss); and adjusted earnings (loss) per share. We use these non-GAAP financial measures internally to facilitate period-to-period comparisons and analysis of our operating performance and liquidity, and believe they are useful to investors as a supplement to GAAP measures in analyzing, trending and benchmarking the

 


 

performance and value of our business. However, these measures are not intended to be a substitute for those reported in accordance with GAAP. These measures may be different from non-GAAP financial measures used by other companies, even when similar terms are used to identify such measures.

For reconciliations of historical non-GAAP financial measures to the most comparable financial measures under GAAP, see Tables A1, A2 and B accompanying this release.

In order to calculate these non-GAAP financial measures, we make targeted adjustments to certain GAAP financial line items found on our Consolidated Statement of Operations, backing out non-recurring or unique items or items that we believe otherwise distort the underlying results and trends of the ongoing business. We have excluded the following items from one or more of our non-GAAP financial measures for the periods presented:

Selling, general and administrative expenses. We exclude a portion of SG&A expense and operating expenses related to transaction expenses related to acquisitions. Acquisition-related expenses include transaction fees, due diligence costs and other direct costs associated with our acquisitions. These amounts are unrelated to our core performance during any particular period and are impacted by the timing of the acquisition. We exclude acquisition-related expenses from our SG&A expense and total operating expenses to provide investors a method to compare our operating results to prior periods and to peer companies, as such amounts can vary significantly based on the frequency of acquisitions and the magnitude of acquisition expenses.

Change in estimated value of assets held for sale.  The change in estimated value of assets held for sale represents our estimated change in the value of certain properties held for sale.  These amounts are non-cash losses, and are unrelated to our core performance during any particular period. We believe it is useful to exclude these amounts in order to better understand our business performance and allow investors to compare our results with peer companies.

Loss on extinguishment of debt.   Loss on extinguishment of debt represents the unamortized debt issuance costs related to our recently terminated KeyBank credit agreement.  These amounts are non-cash losses, and are unrelated to our core performance during any particular period. We believe it is useful to exclude these amounts in order to better understand our business performance and allow investors to compare our results with peer companies.

Interest expense – amortization of debt discount.  Amortization of debt discount and debt issuance costs are primarily related to our working capital lines of credit and term loans. These amounts are non-cash charges and are unrelated to our core performance during any particular period. We believe it is useful to exclude these amounts in order to better understand our business performance and allow investors to compare our results with peer companies.

Descriptions of the non-GAAP financial measures included in this release and the accompanying tables are as follows:

 


 

Adjusted net income (loss) and non-GAAP earnings (loss) per share.  We define non-GAAP net income (loss) as net income (loss) less non-recurring transaction charges, change in estimated value of assets held for sale, loss on extinguishment of debt, and interest expense - amortization of debt discount.  However, in order to provide a complete picture of our recurring core business operating results, we also exclude from non-GAAP net income (loss) the tax effects of these adjustments. We used an effective tax rate that we believe would be applied had our income approximated the non-GAAP net income (loss) for the presented periods. We caution investors that the tax effects of these adjustments are based on management's estimates. We believe that these non-GAAP financial measures provide useful supplemental information for evaluating our operating performance.

Adjusted EBITDA is a non-GAAP financial measure that we define as GAAP net income (loss), adjusted to exclude non-recurring transaction costs, depreciation and amortization, non-cash stock-based compensation, foreign currency (gain) loss, change in estimated value of assets held for sale, loss on extinguishment of debt, interest expense – amortization of debt discount, interest expense, and provision for income taxes. We believe that the use of adjusted EBITDA is useful to investors and other users of our financial statements in evaluating our operating performance because it provides them with an additional tool to compare business performance across companies and across periods. We use adjusted EBITDA in conjunction with traditional GAAP operating performance measures as part of our overall assessment of our performance, for planning purposes, including the preparation of our annual operating budget, to evaluate the effectiveness of our business strategies and to communicate with our board of directors concerning our financial performance. Management does not place undue reliance on adjusted EBITDA as its only measure of operating performance. Adjusted EBITDA should not be considered as a substitute for other measures of financial performance reported in accordance with GAAP.

About S&W Seed Company
Founded in 1980, S&W Seed Company is a global agricultural company headquartered in Longmont, Colorado. S&W’s vision is to be the world’s preferred proprietary seed company which supplies a range of forage and specialty crop products and supports the growing global demand for animal proteins and healthier consumer diets. S&W is a global leader in proprietary alfalfa and sorghum seeds, with significant research and development, production and distribution capabilities. S&W’s product portfolio also includes hybrid sunflower and wheat and the Company is utilizing its research and breeding expertise to develop and produce stevia, the all-natural, zero calorie sweetener for the food and beverage industry. For more information, please visit www.swseedco.com.

Safe Harbor Statement
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually” or “projected.” Forward-looking statements in this release include, but are not limited to, statements regarding the potential revenue growth and gross margin expansion, and the contribution to such growth from a multi-crop portfolio; plans

 


 

for further research and collaboration trials of ATS hybrids; anticipated benefits and progress of our advanced trait technologies, including our ATS hybrids; expectations regarding timing and quantity of seed production for ATS hybrids and initial distribution; strategic initiatives, including plans to leverage unique technologies across other products and geographies to add incremental value; positioning to execute on our strategies; and expectations regarding improvements in gross margins due to seasonal sales of hybrid sorghum; anticipated revenue growth in fiscal 2020, revenue outlook for 2020 and gross margin outlook for 2020; the accretive value of any future acquisitions; and statements regarding the advancement of our strategic plans.  You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that future acquisitions may not yield the anticipated benefits; sales during the high-volume selling season may be lower than expected; the realignment of our organization across geographic lines and to benefit from a multi-crop portfolio may not meet our expectations; our strategic initiatives may not achieve the expected results; and the risks associated with our ability to successfully optimize and commercialize our business. These and other risks are identified in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended June 30, 2019 and in other filings subsequently made by the Company with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

 

 

 


TABLE A1

 

S&W SEED COMPANY

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

 

Three Months Ended

December 31,

 

 

 

Three Months Ended

December 31,

 

 

 

 

2019

 

 

 

2018

 

 

 

 

GAAP

 

 

 

NON-GAAP

Adjustments

 

 

 

NON-GAAP

Adjusted

 

 

 

GAAP

 

 

 

NON-GAAP

Adjustments

 

 

 

NON-GAAP

Adjusted

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product and other

 

$

 

12,353,100

 

 

$

 

-

 

 

$

 

12,353,100

 

 

$

 

18,580,996

 

 

$

 

-

 

 

$

 

18,580,996

 

Total revenue

 

 

 

12,353,100

 

 

 

 

-

 

 

 

 

12,353,100

 

 

 

 

18,580,996

 

 

 

 

-

 

 

 

 

18,580,996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product and other

 

 

 

10,160,727

 

 

 

 

-

 

 

 

 

10,160,727

 

 

 

 

13,897,455

 

 

 

 

-

 

 

 

 

13,897,455

 

Total cost of revenue

 

 

 

10,160,727

 

 

 

 

-

 

 

 

 

10,160,727

 

 

 

 

13,897,455

 

 

 

 

-

 

 

 

 

13,897,455

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

 

2,192,373

 

 

 

 

-

 

 

 

 

2,192,373

 

 

 

 

4,683,541

 

 

 

 

-

 

 

 

 

4,683,541

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

 

5,119,598

 

 

 

 

(178,073

)

 

 

 

4,941,525

 

 

 

 

4,342,696

 

 

 

 

(586,800

)

 

 

 

3,755,896

 

Research and development expenses

 

 

 

1,671,873

 

 

 

 

-

 

 

 

 

1,671,873

 

 

 

 

1,373,554

 

 

 

 

-

 

 

 

 

1,373,554

 

Depreciation and amortization

 

 

 

1,346,004

 

 

 

 

-

 

 

 

 

1,346,004

 

 

 

 

1,035,606

 

 

 

 

-

 

 

 

 

1,035,606

 

(Gain) loss on disposal of property, plant and equipment

 

 

 

(1,500

)

 

 

 

-

 

 

 

 

(1,500

)

 

 

 

3,463

 

 

 

 

-

 

 

 

 

3,463

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

 

8,135,975

 

 

 

 

(178,073

)

 

 

 

7,957,902

 

 

 

 

6,755,319

 

 

 

 

(586,800

)

 

 

 

6,168,519

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

 

(5,943,602

)

 

 

 

178,073

 

 

 

 

(5,765,529

)

 

 

 

(2,071,778

)

 

 

 

586,800

 

 

 

 

(1,484,978

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency gain

 

 

 

(112,363

)

 

 

 

-

 

 

 

 

(112,363

)

 

 

 

(32,987

)

 

 

 

-

 

 

 

 

(32,987

)

Change in estimated value of assets held for sale

 

 

 

7,238

 

 

 

 

(7,238

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Loss on extinguishment of debt

 

 

 

140,638

 

 

 

 

(140,638

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Interest expense - amortization of debt discount

 

 

 

111,810

 

 

 

 

(111,810

)

 

 

 

-

 

 

 

 

68,914

 

 

 

 

(68,914

)

 

 

 

-

 

Interest expense

 

 

 

501,781

 

 

 

 

-

 

 

 

 

501,781

 

 

 

 

641,479

 

 

 

 

-

 

 

 

 

641,479

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

 

(6,592,706

)

 

 

 

437,759

 

 

 

 

(6,154,947

)

 

 

 

(2,749,184

)

 

 

 

655,714

 

 

 

 

(2,093,470

)

Provision for income taxes

 

 

 

23,290

 

 

 

 

-

 

 

 

 

23,290

 

 

 

 

(4,801

)

 

 

 

-

 

 

 

 

(4,801

)

Net loss

 

$

 

(6,615,996

)

 

$

 

437,759

 

 

$

 

(6,178,237

)

 

$

 

(2,744,383

)

 

$

 

655,714

 

 

$

 

(2,088,669

)

Net income (loss) attributed to noncontrolling interests

 

 

 

48,861

 

 

 

 

-

 

 

 

 

48,861

 

 

 

 

21,673

 

 

 

 

-

 

 

 

 

21,673

 

Net loss attributable to S&W Seed Company

 

$

 

(6,664,857

)

 

$

 

437,759

 

 

$

 

(6,227,098

)

 

$

 

(2,766,056

)

 

 

$

655,714

 

 

$

 

(2,110,342

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to S&W Seed Company per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.20

)

 

 

 

 

 

 

$

 

(0.19

)

 

$

 

(0.09

)

 

 

 

 

 

 

$

 

(0.07

)

Diluted

 

$

 

(0.20

)

 

 

 

 

 

 

$

 

(0.19

)

 

$

 

(0.09

)

 

 

 

 

 

 

$

 

(0.07

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

33,301,578

 

 

 

 

 

 

 

 

 

33,301,578

 

 

 

 

29,153,852

 

 

 

 

 

 

 

 

 

29,153,852

 

Diluted

 

 

 

33,301,578

 

 

 

 

 

 

 

 

 

33,301,578

 

 

 

 

29,153,852

 

 

 

 

 

 

 

 

 

29,153,852

 

 

 

 


TABLE A2

 

S&W SEED COMPANY

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 


 

 

 

Six Months Ended

 

 

 

Six Months Ended

 

 

 

 

December 31,

 

 

 

December 31,

 

 

 

 

2019

 

 

 

2018

 

 

 

 

 

 

 

 

 

NON-GAAP

 

 

 

NON-GAAP

 

 

 

 

 

 

 

 

NON-GAAP

 

 

 

NON-GAAP

 

 

 

 

GAAP

 

 

 

Adjustments

 

 

 

Adjusted

 

 

 

GAAP

 

 

 

Adjustments

 

 

 

Adjusted

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product and other

 

$

 

24,625,557

 

 

 

 

-

 

 

$

 

24,625,557

 

 

$

 

44,701,133

 

 

 

 

-

 

 

$

 

44,701,133

 

Total revenue

 

 

 

24,625,557

 

 

 

 

-

 

 

 

 

24,625,557

 

 

 

 

44,701,133

 

 

 

 

-

 

 

 

 

44,701,133

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product and other

 

 

 

19,360,313

 

 

 

 

-

 

 

 

 

19,360,313

 

 

 

 

34,554,463

 

 

 

 

-

 

 

 

 

34,554,463

 

Total cost of revenue

 

 

 

19,360,313

 

 

 

 

-

 

 

 

 

19,360,313

 

 

 

 

34,554,463

 

 

 

 

-

 

 

 

 

34,554,463

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

 

5,265,244

 

 

 

 

-

 

 

 

 

5,265,244

 

 

 

 

10,146,670

 

 

 

 

-

 

 

 

 

10,146,670

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

 

9,767,924

 

 

 

 

(356,359

)

 

 

 

9,411,565

 

 

 

 

7,230,074

 

 

 

 

(995,316

)

 

 

 

6,234,758

 

Research and development expenses

 

 

 

3,260,064

 

 

 

 

-

 

 

 

 

3,260,064

 

 

 

 

2,365,667

 

 

 

 

-

 

 

 

 

2,365,667

 

Depreciation and amortization

 

 

 

2,410,802

 

 

 

 

-

 

 

 

 

2,410,802

 

 

 

 

1,890,714

 

 

 

 

-

 

 

 

 

1,890,714

 

(Gain) loss on disposal of property, plant and equipment

 

 

 

(13,075

)

 

 

 

-

 

 

 

 

(13,075

)

 

 

 

3,463

 

 

 

 

-

 

 

 

 

3,463

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

 

15,425,715

 

 

 

 

(356,359

)

 

 

 

15,069,356

 

 

 

 

11,489,918

 

 

 

 

(995,316

)

 

 

 

10,494,602

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

 

(10,160,471

)

 

 

 

356,359

 

 

 

 

(9,804,112

)

 

 

 

(1,343,248

)

 

 

 

995,316

 

 

 

 

(347,932

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency gain

 

 

 

(14,176

)

 

 

 

-

 

 

 

 

(14,176

)

 

 

 

(58,430

)

 

 

 

-

 

 

 

 

(58,430

)

Change in estimated value of assets held for sale

 

 

 

92,931

 

 

 

 

(92,931

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Loss on extinguishment of debt

 

 

 

140,638

 

 

 

 

(140,638

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Interest expense - amortization of debt discount

 

 

 

297,712

 

 

 

 

(297,712

)

 

 

 

-

 

 

 

 

135,392

 

 

 

 

(135,392

)

 

 

 

-

 

Interest expense

 

 

 

938,279

 

 

 

 

-

 

 

 

 

938,279

 

 

 

 

1,298,709

 

 

 

 

-

 

 

 

 

1,298,709

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

 

(11,615,855

)

 

 

 

887,640

 

 

 

 

(10,728,215

)

 

 

 

(2,718,919

)

 

 

 

1,130,708

 

 

 

 

(1,588,211

)

Provision for income taxes

 

 

 

24,520

 

 

 

 

-

 

 

 

 

24,520

 

 

 

 

4,533

 

 

 

 

-

 

 

 

 

4,533

 

Net loss

 

$

 

(11,640,375

)

 

 

 

887,640

 

 

$

 

(10,752,735

)

 

$

 

(2,723,452

)

 

 

 

1,130,708

 

 

$

 

(1,592,744

)

Net income (loss) attributed to noncontrolling interests

 

 

 

(50,028

)

 

 

 

-

 

 

 

 

(50,028

)

 

 

 

21,673

 

 

 

 

-

 

 

 

 

21,673

 

Net loss attributable to S&W Seed Company

 

$

 

(11,590,347

)

 

 

$

887,640

 

 

$

 

(10,702,707

)

 

$

 

(2,745,125

)

 

 

$

1,130,708

 

 

$

 

(1,614,417

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to S&W Seed Company per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.35

)

 

 

 

 

 

 

$

 

(0.32

)

 

$

 

(0.10

)

 

 

 

 

 

 

$

 

(0.06

)

Diluted

 

$

 

(0.35

)

 

 

 

 

 

 

$

 

(0.32

)

 

$

 

(0.10

)

 

 

 

 

 

 

$

 

(0.06

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

33,294,344

 

 

 

 

 

 

 

 

 

33,294,344

 

 

 

 

26,996,483

 

 

 

 

 

 

 

 

 

26,996,483

 

Diluted

 

 

 

33,294,344

 

 

 

 

 

 

 

 

 

33,294,344

 

 

 

 

26,996,483

 

 

 

 

 

 

 

 

 

26,996,483

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


TABLE B

 

S&W SEED COMPANY

ITEMIZED RECONCILIATION BETWEEN NET INCOME (LOSS) AND NON-GAAP ADJUSTED EBITDA

(UNAUDITED)

 

 

 

 

Three Months Ended

 

 

 

Six Months Ended

 

 

 

 

December 31,

 

 

 

December 31,

 

 

 

 

2019

 

 

 

2018

 

 

 

2019

 

 

 

2018

 

Net loss attributable to S&W Seed Company

 

$

 

(6,664,857

)

 

$

 

(2,766,056

)

 

$

 

(11,590,347

)

 

$

 

(2,745,125

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-recurring transaction costs

 

 

 

178,073

 

 

 

 

586,800

 

 

 

 

356,359

 

 

 

 

995,316

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash stock based compensation

 

 

 

309,767

 

 

 

 

222,153

 

 

 

 

468,604

 

 

 

 

377,458

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

1,346,004

 

 

 

 

1,035,606

 

 

 

 

2,410,802

 

 

 

 

1,890,715

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency gain

 

 

 

(112,363

)

 

 

 

(32,987

)

 

 

 

(14,176

)

 

 

 

(58,430

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in estimated value of assets held for sale

 

 

 

7,238

 

 

 

 

-

 

 

 

 

92,931

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on extinguishment of debt

 

 

 

140,638

 

 

 

 

-

 

 

 

 

140,638

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense - amortization of debt discount

 

 

 

111,810

 

 

 

 

68,914

 

 

 

 

297,712

 

 

 

 

135,392

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

 

501,781

 

 

 

 

641,479

 

 

 

 

938,279

 

 

 

 

1,298,709

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

23,290

 

 

 

 

(4,801

)

 

 

 

24,520

 

 

 

 

4,533

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Adjusted EBITDA

 

$

 

(4,158,619

)

 

$

 

(248,892

)

 

$

 

(6,874,678

)

 

$

 

1,898,568

 

 

 

 

 

 


S&W SEED COMPANY

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

 

 

 

December 31,

 

 

 

June 30,

 

 

 

 

2019

 

 

 

2019

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

2,353,072

 

 

$

 

3,431,802

 

Accounts receivable, net

 

 

 

10,243,690

 

 

 

 

13,380,464

 

Unbilled accounts receivable, net

 

 

 

524,511

 

 

 

 

 

Inventories, net

 

 

 

75,610,319

 

 

 

 

71,295,520

 

Prepaid expenses and other current assets

 

 

 

1,598,496

 

 

 

 

1,687,490

 

Assets held for sale

 

 

 

 

 

 

 

1,850,000

 

TOTAL CURRENT ASSETS

 

 

 

90,330,088

 

 

 

 

91,645,276

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

 

20,344,674

 

 

 

 

20,634,949

 

Intangibles, net

 

 

 

34,217,214

 

 

 

 

32,714,484

 

Other assets

 

 

 

4,627,839

 

 

 

 

1,369,560

 

TOTAL ASSETS

 

$

 

149,519,815

 

 

$

 

146,364,269

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

13,507,963

 

 

$

 

6,930,829

 

Deferred revenue

 

 

 

10,121,405

 

 

 

 

9,054,549

 

Accrued expenses and other current liabilities

 

 

 

5,127,747

 

 

 

 

6,073,110

 

Lines of credit, net

 

 

 

16,995,697

 

 

 

 

10,755,548

 

Current portion of long-term debt, net

 

 

 

1,394,154

 

 

 

 

1,113,502

 

TOTAL CURRENT LIABILITIES

 

 

 

47,146,966

 

 

 

 

33,927,538

 

 

 

 

 

 

 

 

 

 

 

 

Long-term debt, net, less current portion

 

 

 

11,392,796

 

 

 

 

12,158,095

 

Other non-current liabilities

 

 

 

2,224,284

 

 

 

 

280,424

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

 

60,764,046

 

 

 

 

46,366,057

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value; 5,000,000 shares authorized;

   no shares issued and outstanding

 

 

 

 

 

 

 

 

 

 

Common stock, $0.001 par value; 50,000,000 shares authorized; 33,329,566

   issued and 33,304,566 outstanding at December 31, 2019; 33,303,218 issued and

   33,278,218 outstanding at June 30, 2019;

 

 

 

33,329

 

 

 

 

33,303

 

Treasury stock, at cost, 25,000 shares

 

 

 

(134,196

)

 

 

 

(134,196

)

Additional paid-in capital

 

 

 

137,204,276

 

 

 

 

136,751,875

 

Accumulated deficit

 

 

 

(42,056,965

)

 

 

 

(30,466,618

)

Accumulated other comprehensive loss

 

 

 

(6,192,962

)

 

 

 

(6,138,467

)

Noncontrolling interests

 

 

 

(97,713

)

 

 

 

(47,685

)

TOTAL STOCKHOLDERS' EQUITY

 

 

 

88,755,769

 

 

 

 

99,998,212

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

 

$

 

149,519,815

 

 

$

 

146,364,269

 

 

 

 

 

 


S&W SEED COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 

 

Six Months Ended December 31,

 

 

 

 

2019

 

 

 

2018

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

 

(11,640,375

)

 

$

 

(2,723,452

)

Adjustments to reconcile net loss from operating activities to net

   cash used in operating activities

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

468,604

 

 

 

 

377,458

 

Change in allowance for doubtful accounts

 

 

 

(36,018

)

 

 

 

(154,364

)

Inventory write-down

 

 

 

818,099

 

 

 

 

 

Depreciation and amortization

 

 

 

2,410,802

 

 

 

 

1,890,715

 

(Gain) on disposal of property, plant and equipment

 

 

 

(13,075

)

 

 

 

3,463

 

Change in foreign exchange contracts

 

 

 

(73,677

)

 

 

 

2,626

 

Change in estimated value of assets held for sale

 

 

 

92,931

 

 

 

 

-

 

Loss on debt extinguishment

 

 

 

140,638

 

 

 

 

-

 

Amortization of debt discount

 

 

 

297,712

 

 

 

 

135,392

 

Changes in:

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

 

3,169,182

 

 

 

 

(8,336,183

)

Unbilled accounts receivable

 

 

 

(524,511

)

 

 

 

(11,206,984

)

Inventories

 

 

 

(5,193,721

)

 

 

 

(21,513,547

)

Prepaid expenses and other current assets

 

 

 

16,829

 

 

 

 

123,752

 

Other non-current asset

 

 

 

31,935

 

 

 

 

-

 

Accounts payable

 

 

 

6,643,907

 

 

 

 

23,698,244

 

Deferred revenue

 

 

 

1,066,964

 

 

 

 

1,458,655

 

Accrued expenses and other current liabilities

 

 

 

(943,890

)

 

 

 

384,628

 

Other non-current liabilities

 

 

 

(218,475

)

 

 

 

(40,855

)

Net cash used in operating activities

 

 

 

(3,486,139

)

 

 

 

(15,900,452

)

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

 

 

Additions to property, plant and equipment

 

 

 

(1,447,549

)

 

 

 

(336,623

)

Proceeds from disposal of property, plant and equipment

 

 

 

20,075

 

 

 

 

24,106

 

Proceeds from sale of assets held for sale

 

 

 

1,757,069

 

 

 

 

-

 

Additions to internal use software

 

 

 

-

 

 

 

 

(43,000

)

Acquisition of business, net of cash acquired

 

 

 

-

 

 

 

 

(26,354,951

)

Acquisition of wheat assets

 

 

 

(2,633,000

)

 

 

 

-

 

Net cash used in investing activities

 

 

 

(2,303,405

)

 

 

 

(26,710,468

)

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

 

 

Net proceeds from sale of common stock

 

 

 

 

 

 

 

4,927,682

 

Net proceeds from sale of preferred stock

 

 

 

-

 

 

 

 

22,420,462

 

Taxes paid related to net share settlements of stock-based compensation awards

 

 

 

(16,177

)

 

 

 

(25,497

)

Borrowings and repayments on lines of credit, net

 

 

 

6,648,102

 

 

 

 

14,299,326

 

Borrowings of long-term debt

 

 

 

258,721

 

 

 

 

2,369,071

 

Debt issuance costs

 

 

 

(879,655

)

 

 

 

(354,589

)

Repayments of long-term debt

 

 

 

(1,147,447

)

 

 

 

(2,682,056

)

Net cash provided by financing activities

 

 

 

4,863,544

 

 

 

 

40,954,399

 

EFFECT OF EXCHANGE RATE CHANGES ON CASH

 

 

 

(152,730

)

 

 

 

(192,992

)

 

 

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS

 

 

 

(1,078,730

)

 

 

 

(1,849,513

)

 

 

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS, beginning of the period

 

$

 

3,431,802

 

 

$

 

4,320,894

 

 

 

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS, end of period

 

$

 

2,353,072

 

 

$

 

2,471,381